WCG Foundation Progress Report, January 24, 2017
WCG Foundation (WCGF) has received $15,000 from GlaxoSmithKline (GSK) for the Foundation’s Expanded Access Project. The project helps desperately ill patients who have exhausted all treatment and clinical trial options and want to try experimental medicines.
WCGF will use the GSK grant to help institutional review boards (IRB) streamline the process that patients must navigate to gain access to investigational drugs and devices. Learn more.